Stay updated on Long-term Safety of KarXT in Schizophrenia Clinical Trial

Sign up to get notified when there's something new on the Long-term Safety of KarXT in Schizophrenia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-term Safety of KarXT in Schizophrenia Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The history adds a note that the study is no longer looking for participants, signaling termination or pause of recruitment. It also includes a new revision version v3.6.0 and notes the removal of the previous revision v3.5.5, reflecting an update to the study record.
    Difference
    0.6%
    Check dated 2026-06-13T00:19:49.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The record history now shows a new version (v3.5.5) replacing v3.5.4, indicating a platform update to the history tracking rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-06-05T18:01:57.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    New revision entry v3.5.4 was added to the record history, replacing the prior v3.5.3. This reflects an updated version of the study record without changing the reported study details.
    Difference
    0.2%
    Check dated 2026-05-15T05:37:19.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    A new revision label, v3.5.3, was added to the Record History and the previous label, v3.5.2, was removed, reflecting an update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-04-30T18:01:57.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    A new history entry Revision: v3.5.2 was added and Revision: v3.5.0 was removed from the study record history.
    Difference
    0.1%
    Check dated 2026-04-16T10:57:20.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Sponsor name updated to Karuna Therapeutics, Inc., a Bristol Myers Squibb company, replacing Karuna Therapeutics.
    Difference
    0.2%
    Check dated 2026-04-02T00:44:13.000Z thumbnail image

Stay in the know with updates to Long-term Safety of KarXT in Schizophrenia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-term Safety of KarXT in Schizophrenia Clinical Trial page.